May 26, 2025

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: High Analyst Confidence and a Promising 76% Upside Potential

BridgeBio Pharma, Inc. (BBIO), a leading player in the biotechnology sector, is capturing investor attention with its innovative approach to treating genetic diseases and cancers. With..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring an 18% Upside Potential with Strong Buy Ratings

For investors looking to navigate the healthcare sector, Molina Healthcare Inc (NYSE: MOH) stands out as a compelling opportunity, particularly in light of its robust growth..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 29% Potential Upside in the Medical Device Sector

Teleflex Incorporated (NYSE: TFX), a notable player in the healthcare sector, has captured attention with its diversified portfolio of single-use medical devices. With a current market..

Summit Therapeutics Inc. (SMMT): Biotech Stock with a 47% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) is capturing the attention of investors within the biotechnology sector, not only for its groundbreaking approach to drug development but also..

The Cigna Group (CI) Stock Analysis: A Healthcare Giant with an 18.74% Potential Upside

For investors on the lookout for promising opportunities in the healthcare sector, The Cigna Group (NYSE: CI) offers an intriguing prospect. With a market capitalization of..

Alnylam Pharmaceuticals, Inc. (ALNY): Investor Outlook Reveals 10.57% Potential Upside and Robust Pipeline

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, continues to intrigue investors with its promising pipeline and strategic collaborations. Headquartered in Cambridge, Massachusetts,..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Powerhouse with 22.85% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is carving a niche in the biotechnology sector with its innovative enzyme-based drug delivery solutions. With a market capitalization of $6.72..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Growth Potential with a 13.80% Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, has been capturing investor attention with its innovative medical instruments and supplies. Based..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Exploring a 70.97% Potential Upside

Investors on the lookout for opportunities in the biotechnology sector should consider Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a company headquartered in Dublin, Ireland. Specializing in developing..

BioNTech SE (BNTX) Stock Analysis: A 34.66% Potential Upside Amidst Biotech Challenges

BioNTech SE (BNTX), a prominent player in the biotechnology sector, has been a focal point for investors with its promising pipeline of immunotherapies aimed at combating..

BrightSpring Health Services, I (BTSG)

⚠️ No article content returned.

..

HCA Healthcare, Inc. (HCA) Stock Analysis: Robust Revenues and Analyst Confidence Highlight Investment Potential

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable entity in the healthcare sector, particularly within the medical care facilities industry. With a robust market capitalization..

Repligen Corporation (RGEN) Stock Analysis: Navigating a Potential 54.99% Upside with Strong Buy Ratings

For investors keen on the healthcare sector, Repligen Corporation (NASDAQ: RGEN) presents a compelling case for consideration, particularly with its attractive potential upside of nearly 55%...

Centene Corporation (CNC) Stock Analysis: A Healthcare Leader with 38.44% Potential Upside

Investors eyeing the healthcare sector should pay close attention to Centene Corporation (NYSE: CNC), a prominent player in the healthcare plans industry. With a market capitalization..

Natera, Inc. (NTRA) Stock Analysis: Unpacking a 25% Upside Potential in the Diagnostics Arena

Natera, Inc. (NASDAQ: NTRA) stands prominently in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Austin, Texas, this innovative company has carved..

Legend Biotech Corporation (LEGN): Investor Outlook Highlights 165% Potential Upside Amidst Strong Buy Ratings

Legend Biotech Corporation (NASDAQ: LEGN) is capturing the attention of investors with its promising potential upside of 165.40%, driven by an impressive array of buy ratings..

Ascendis Pharma A/S (ASND) Stock Analysis: Unpacking a 38.64% Potential Upside

Ascendis Pharma A/S (NASDAQ: ASND), a Danish biopharmaceutical company, has made headlines in the healthcare sector with its promising therapeutic developments and strategic market positioning. As..

Glaukos Corporation (GKOS) Stock Analysis: A 27% Upside Potential in the Medical Devices Sector

Glaukos Corporation (NYSE: GKOS), a leading player in the healthcare sector, specifically within the medical devices industry, offers a compelling proposition for investors seeking growth in..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Navigating a 3.21% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a formidable player in the healthcare sector, specifically within the niche of over-the-counter (OTC) drug manufacturing. With a..

Axsome Therapeutics (AXSM) Stock Analysis: A Biotech Gem with 68% Upside Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a prominent player in the biotechnology sector, has captured investor interest due to its innovative focus on central nervous system (CNS)..

Search

Funds

May 26, 2025

Search

Funds

May 26, 2025

FTSE 100

Funds